1. Home
  2. HURN vs AMPH Comparison

HURN vs AMPH Comparison

Compare HURN & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HURN
  • AMPH
  • Stock Information
  • Founded
  • HURN 2002
  • AMPH 1996
  • Country
  • HURN United States
  • AMPH United States
  • Employees
  • HURN N/A
  • AMPH N/A
  • Industry
  • HURN Professional Services
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • HURN Consumer Discretionary
  • AMPH Health Care
  • Exchange
  • HURN Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • HURN 2.6B
  • AMPH 1.1B
  • IPO Year
  • HURN 2004
  • AMPH 2014
  • Fundamental
  • Price
  • HURN $137.16
  • AMPH $23.18
  • Analyst Decision
  • HURN Strong Buy
  • AMPH Hold
  • Analyst Count
  • HURN 4
  • AMPH 5
  • Target Price
  • HURN $170.75
  • AMPH $38.00
  • AVG Volume (30 Days)
  • HURN 186.2K
  • AMPH 507.4K
  • Earning Date
  • HURN 07-29-2025
  • AMPH 08-06-2025
  • Dividend Yield
  • HURN N/A
  • AMPH N/A
  • EPS Growth
  • HURN 92.74
  • AMPH N/A
  • EPS
  • HURN 6.67
  • AMPH 2.77
  • Revenue
  • HURN $1,525,814,000.00
  • AMPH $730,659,000.00
  • Revenue This Year
  • HURN $11.50
  • AMPH $0.67
  • Revenue Next Year
  • HURN $7.48
  • AMPH $5.18
  • P/E Ratio
  • HURN $20.64
  • AMPH $8.26
  • Revenue Growth
  • HURN 8.98
  • AMPH 8.05
  • 52 Week Low
  • HURN $96.45
  • AMPH $22.64
  • 52 Week High
  • HURN $155.00
  • AMPH $53.96
  • Technical
  • Relative Strength Index (RSI)
  • HURN 40.46
  • AMPH 33.77
  • Support Level
  • HURN $130.72
  • AMPH $24.35
  • Resistance Level
  • HURN $135.28
  • AMPH $25.04
  • Average True Range (ATR)
  • HURN 3.38
  • AMPH 0.72
  • MACD
  • HURN -0.34
  • AMPH -0.33
  • Stochastic Oscillator
  • HURN 25.51
  • AMPH 3.43

About HURN Huron Consulting Group Inc.

Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: